169 related articles for article (PubMed ID: 21704075)
1. ALS: focus on purinergic signalling.
Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
Amadio S; Apolloni S; D'Ambrosi N; Volonté C
J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
[TBL] [Abstract][Full Text] [Related]
3. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
4. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
5. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
6. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
Volonté C; D'Ambrosi N
FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
8. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
9. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation, COX-2, and ALS--a dual role?
Consilvio C; Vincent AM; Feldman EL
Exp Neurol; 2004 May; 187(1):1-10. PubMed ID: 15081582
[TBL] [Abstract][Full Text] [Related]
11. Axon guidance proteins: novel therapeutic targets for ALS?
Schmidt ER; Pasterkamp RJ; van den Berg LH
Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
[TBL] [Abstract][Full Text] [Related]
12. Role of purinergic receptors in CNS function and neuroprotection.
Tozaki-Saitoh H; Tsuda M; Inoue K
Adv Pharmacol; 2011; 61():495-528. PubMed ID: 21586368
[TBL] [Abstract][Full Text] [Related]
13. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into how purines regulate pituitary cell function.
Rees DA; Scanlon MF; Ham J
Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
[TBL] [Abstract][Full Text] [Related]
15. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
Papadeas ST; Maragakis NJ
Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling involved in Müller cell function in the mammalian retina.
Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
18. Functional microglia neurotransmitters in amyotrophic lateral sclerosis.
Volonté C; Amadio S; Fabbrizio P; Apolloni S
Semin Cell Dev Biol; 2019 Oct; 94():121-128. PubMed ID: 31009755
[TBL] [Abstract][Full Text] [Related]
19. Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders.
Matute C; Cavaliere F
Semin Cell Dev Biol; 2011 Apr; 22(2):252-9. PubMed ID: 21320622
[TBL] [Abstract][Full Text] [Related]
20. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
Volonté C; Amadio S
Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]